PGF and glioblastoma: Treatment responses of recurrent glioblastoma patients (n = 26) treated with the VEGF and PlGF sequestering drug aflibercept were not associated with significant changes in plasma protein levels of VEGF, despite initial reduction of this marker in plasma and subsequent increases of circulating VEGF and PlGF after 2 weeks of treatment [62].